“Tick-tock, tick-tock.” Hearing the clock ticking at night during intermittent awakenings is more than just frustrating, it can impair deep sleep. This phase has many restorative functions, including blood pressure regulation and, as emerging evidence suggests, improvement in body composition.
While many people turn to melatonin, the challenge is that most melatonin supplements fade too quickly, limiting their ability to support healthy deep sleep (also known as “slow-wave sleep”). During a healthy night’s sleep (approximately 8 hours), deep sleep accounts for 13% to 23% of total sleep time, or approximately 60 to 110 minutes per night. With aging, however, total sleep time, sleep efficiency, and the duration of deep sleep decline, while the number of awakenings and the amount of time spent awake during the night increase.
How a Specific Melatonin Protects Slow-Wave Sleep
A common sleep complaint is waking up intermittently throughout the night. These awakenings interrupt deep sleep, forcing the brain to repeatedly restart the sleep cycle from its initial stages. While many individuals focus on falling asleep more quickly, others consider staying asleep throughout the night to be their primary sleep goal. Therefore, a melatonin that supports a consolidated 7 to 8 hours of sleep with minimal awakenings is highly desirable.
Melotime™ was developed to support the natural physiology of overnight sleep, rather than simply promoting sleep onset. Most conventional melatonin supplements are rapidly metabolized, resulting in benefits that are concentrated in the early part of the night while leaving the second half of sleep inadequately supported. Melotime™ was designed to address this limitation. In a pharmacokinetic study comparing Melotime™ with immediate-release melatonin, participants receiving 5mg melatonin (11 mg Melotime™) maintained higher plasma melatonin concentrations during the second half of the night (delayed phase) and exhibited a prolonged elimination half-life of 5.10 hours, compared with just 1.01 hours for immediate-release melatonin. These findings demonstrated Melotime™’s ability to more closely mimic the body’s natural overnight melatonin secretion profile.
Building on this pharmacokinetic advantage, new clinical evidence now demonstrates that Melotime™ can deliver meaningful sleep benefits at a lower dose of just 2 mg. In a newly published study, adults experiencing poor sleep quality received 2 mg Melatonin (4.44 mg Melotime™) for 28 days. Sleep outcomes were evaluated using polysomnography (PSG), the gold-standard objective method for assessing sleep architecture and quality. Compared with placebo, participants receiving Melotime™ experienced a measurable increase in total sleep time over the 28-day study period, while placebo group showed a net decline. This difference continued to widen throughout the 28-day study period, suggesting sustained improvement with continued supplementation. In addition, Melotime™ significantly reduced sleep onset latency, enabling participants to fall asleep faster, while sleep onset latency worsened in the placebo group. Importantly, Melotime™ significantly reduced wake after sleep onset (WASO) meaning participants spent less time awake after initially falling asleep. Because frequent awakenings can disrupt slow wave sleep, reducing WASO may help preserve this critical stage of sleep. This represents an important marker of sleep quality, and highlights a benefit that many conventional immediate release melatonin formulations often fail to deliver.
Why Deep Sleep Matters
Interrupted slow-wave sleep (deep sleep) can leave even healthy individuals feeling mentally sluggish, with impaired concentration or memory the following day. Numerous studies have demonstrated that slow-wave sleep plays a critical role in memory consolidation and learning. One such study investigated how slow-wave sleep influences memory reactivation. Participants learned pairs of playing cards while being exposed to rose scent before sleep. During slow-wave sleep, the same scent was reintroduced for one group, while control group received an odorless stimulus. The following day, participants who were re-exposed to the scent during slow-wave sleep demonstrated significantly better recall of the card pairs, highlighting the brain’s ability to strengthen memory during deep sleep. This is just one of many studies illustrating the important role that sleep architecture and slow-wave sleep in particular, plays in learning, memory and cognitive performance.
Deep sleep also contributes to clearance of metabolic waste products such as amyloid-beta, a protein that forms plaques, as well as other metabolites. In one study, researchers observed that “the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.” Slow-wave sleep also plays an important role in blood pressure regulation. During this phase, blood pressure normally decreases by up to 20% in a process known as nocturnal dipping. However, this physiological decline is impaired when deep sleep is disrupted. According to one study, every 5% deficiency in the normal nocturnal decline in blood pressure was associated with an approximate 20% greater risk of cardiovascular mortality.
A newly published study has identified the brain circuit that explains why deep sleep is essential for healthy metabolism and brain function. According to researchers, deep sleep activates a neural circuit that regulates the release of growth hormone, supporting muscle and bone strength, metabolism, and even cognitive performance. The researchers mapped the neural circuits underlying this process, revealing a feedback loop in which deep sleep promotes growth hormone release, which in turn helps regulate wakefulness. They suggest that this newly discovered feedback loop helps explain why poor sleep can interfere with growth, muscle repair, fat metabolism, and brain function.
Another new study found that interrupted slow-wave sleep was linked to higher anxiety levels in healthy older adults. The researchers concluded that intact slow-wave activity “may preserve emotional stability by rescuing the brain’s nightly emotional recalibration process, protecting mental health in aging populations.”
Conclusion
Achieving regular deep sleep (slow-wave) is critical for maintaining overall health, resilience, and optimal next-day cognitive functioning. However, modern-day distractions and a tendency toward rumination can result in fragmented sleep and reduced time spent in deep sleep. Practicing good sleep hygiene and maintaining healthy lifestyle habits can help promote restorative sleep, the foundation of optimal health and well-being.
Reviewed by Sneha Sawant Desai, PhD
